SCYX Scynexis Inc

SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.

$8.68
As of 03/03/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
05/02/2014
10,940,119
675,977
$94,960,233
0.00%
SEC Edgar Online
10-Q
10-K
811292200
US8112922005
BMCC9R7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
9.81
0.00
-281.77%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy